Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5 vs 10 Days Phenoxymethylpenicillin for Streptococcal Pharyngotonsillitis
NCT02712307Phase 4Completed
- Start
- Sep 2015
- Primary completion
- Feb 2018
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phenoxymethylpenicillin in streptococcal pharyngitis (2 arms). Primary endpoint: Clinical cure. Started Sep 2015; status: completed.
02
Drugs
phenoxymethylpenicillin
03
Conditions
streptococcal pharyngitis
Beyond the preview
Go deeper on NCT02712307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02712307.